High-output heart failure associated with anagrelide therapy for essential thrombocytosis [3]

Annals of Internal Medicine

Volumn 143, Issue 4, 2005, Pages 311-313

  Engel, Peter J ^a   Johnson, Heide ^a   Baughman, Robert P ^b   Richards, Arthur I ^c  

^a The Carl & Edyth Lindner Center for Research & Education   (United States)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^c Oncology Hematology Care Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; ANAGRELIDE; ENOXIMONE; HYDROXYUREA; MILRINONE;

ADULT; ATRIOVENTRICULAR BLOCK; CASE REPORT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DRUG WITHDRAWAL; EDEMA; ELECTROCARDIOGRAPHY; HEART CATHETERIZATION; HEART OUTPUT; HEART PALPITATION; HUMAN; LETTER; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SUDDEN DEATH; SYMPTOMATOLOGY; TACHYCARDIA; THROMBOCYTOSIS;

EID: 23644458572     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-143-4-200508160-00020     Document Type: Letter

References (6)

1. Braunwald E, Zipes D, Libby P. Heart Disease-A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders; 2001.
2. Anand IS, Florea VG. High output cardiac failure. Curr Treat Options Cardiovasc Med. 2001;3:151-159. [PMID: 11242561]
3. Silverstein MN, Petitt RM, Solberg LA Jr, Fleming JS, Knight RC, Schacter LP. Anagrelide: a new drug for treating thrombocytosis. N Engl J Med. 1988;318:1292-4. [PMID: 3362187]
4. Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group. Am J Med. 1992;92:69-76. [PMID: 1731512]
5. Petitt RM, Silverstein MN, Petrone ME. Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative disorders. Semin Hematol. 1997;34:51-4. [PMID: 9025162]
6. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991;325:1468-75. [PMID: 1944425]